Founded in 2005, the mission of California Stem Cell is to catalyze the efficient development of human therapies based on stem cells.
The key to this goal is the production and supply of clinically relevant human cell populations using a scalable, efficient and highly reproducible process. We generate human embryonic stem cells (hESCs), expand them to clinically and commercially useful numbers, and differentiate them at extremely high purity using fully-defined, proprietary media and cGMP processes that are FDA compliant from day one. And we do this at a fraction of the cost of conventional cell manufacturing.
As a result, CSC can economically supply large quantities of high purity cells for use in our own clinical development pipeline, as well as to companies and institutions worldwide.
California Stem Cell, Inc. is a privately held Delaware Corporation with headquarters and research facilities in Irvine, CA.